244 related articles for article (PubMed ID: 29537311)
1. Casein kinase 1ε and 1α as novel players in polycystic kidney disease and mechanistic targets for (R)-roscovitine and (S)-CR8.
Billot K; Coquil C; Villiers B; Josselin-Foll B; Desban N; Delehouzé C; Oumata N; Le Meur Y; Boletta A; Weimbs T; Grosch M; Witzgall R; Saunier S; Fischer E; Pontoglio M; Fautrel A; Mrug M; Wallace D; Tran PV; Trudel M; Bukanov N; Ibraghimov-Beskrovnaya O; Meijer L
Am J Physiol Renal Physiol; 2018 Jul; 315(1):F57-F73. PubMed ID: 29537311
[TBL] [Abstract][Full Text] [Related]
2. CDK/CK1 inhibitors roscovitine and CR8 downregulate amplified MYCN in neuroblastoma cells.
Delehouzé C; Godl K; Loaëc N; Bruyère C; Desban N; Oumata N; Galons H; Roumeliotis TI; Giannopoulou EG; Grenet J; Twitchell D; Lahti J; Mouchet N; Galibert MD; Garbis SD; Meijer L
Oncogene; 2014 Dec; 33(50):5675-87. PubMed ID: 24317512
[TBL] [Abstract][Full Text] [Related]
3. CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases.
Bettayeb K; Oumata N; Echalier A; Ferandin Y; Endicott JA; Galons H; Meijer L
Oncogene; 2008 Oct; 27(44):5797-807. PubMed ID: 18574471
[TBL] [Abstract][Full Text] [Related]
4. CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD.
Bukanov NO; Moreno SE; Natoli TA; Rogers KA; Smith LA; Ledbetter SR; Oumata N; Galons H; Meijer L; Ibraghimov-Beskrovnaya O
Cell Cycle; 2012 Nov; 11(21):4040-6. PubMed ID: 23032260
[TBL] [Abstract][Full Text] [Related]
5. Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine.
Bukanov NO; Smith LA; Klinger KW; Ledbetter SR; Ibraghimov-Beskrovnaya O
Nature; 2006 Dec; 444(7121):949-52. PubMed ID: 17122773
[TBL] [Abstract][Full Text] [Related]
6. Reduction of ciliary length through pharmacologic or genetic inhibition of CDK5 attenuates polycystic kidney disease in a model of nephronophthisis.
Husson H; Moreno S; Smith LA; Smith MM; Russo RJ; Pitstick R; Sergeev M; Ledbetter SR; Bukanov NO; Lane M; Zhang K; Billot K; Carlson G; Shah J; Meijer L; Beier DR; Ibraghimov-Beskrovnaya O
Hum Mol Genet; 2016 Jun; 25(11):2245-2255. PubMed ID: 27053712
[TBL] [Abstract][Full Text] [Related]
7. Systemic Administration of the Cyclin-Dependent Kinase Inhibitor (S)-CR8 Selectively Reduces Escalated Ethanol Intake in Dependent Rats.
Goulding SP; de Guglielmo G; Carrette LLG; George O; Contet C
Alcohol Clin Exp Res; 2019 Oct; 43(10):2079-2089. PubMed ID: 31403700
[TBL] [Abstract][Full Text] [Related]
8. Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1.
Oumata N; Bettayeb K; Ferandin Y; Demange L; Lopez-Giral A; Goddard ML; Myrianthopoulos V; Mikros E; Flajolet M; Greengard P; Meijer L; Galons H
J Med Chem; 2008 Sep; 51(17):5229-42. PubMed ID: 18698753
[TBL] [Abstract][Full Text] [Related]
9. p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levels.
Park JY; Schutzer WE; Lindsley JN; Bagby SP; Oyama TT; Anderson S; Weiss RH
BMC Nephrol; 2007 Aug; 8():12. PubMed ID: 17714589
[TBL] [Abstract][Full Text] [Related]
10. Targeting dysregulated cell cycle and apoptosis for polycystic kidney disease therapy.
Ibraghimov-Beskrovnaya O
Cell Cycle; 2007 Apr; 6(7):776-9. PubMed ID: 17377490
[TBL] [Abstract][Full Text] [Related]
11. Triptolide delays disease progression in an adult rat model of polycystic kidney disease through the JAK2-STAT3 pathway.
Jing Y; Wu M; Zhang D; Chen D; Yang M; Mei S; He L; Gu J; Qi N; Fu L; Li L; Mei C
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F479-F486. PubMed ID: 29513074
[TBL] [Abstract][Full Text] [Related]
12. Disparate effects of roscovitine on renal tubular epithelial cell apoptosis and senescence: implications for autosomal dominant polycystic kidney disease.
Park JY; Park SH; Weiss RH
Am J Nephrol; 2009; 29(6):509-15. PubMed ID: 19066425
[TBL] [Abstract][Full Text] [Related]
13. Roscovitine targets, protein kinases and pyridoxal kinase.
Bach S; Knockaert M; Reinhardt J; Lozach O; Schmitt S; Baratte B; Koken M; Coburn SP; Tang L; Jiang T; Liang DC; Galons H; Dierick JF; Pinna LA; Meggio F; Totzke F; Schächtele C; Lerman AS; Carnero A; Wan Y; Gray N; Meijer L
J Biol Chem; 2005 Sep; 280(35):31208-19. PubMed ID: 15975926
[TBL] [Abstract][Full Text] [Related]
14. Effects of the cyclin-dependent kinase inhibitor R-roscovitine on eosinophil survival and clearance.
Farahi N; Uller L; Juss JK; Langton AJ; Cowburn AS; Gibson A; Foster MR; Farrow SN; Marco-Casanova P; Sobolewski A; Condliffe AM; Chilvers ER
Clin Exp Allergy; 2011 May; 41(5):673-87. PubMed ID: 21255143
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
[TBL] [Abstract][Full Text] [Related]
16. Prime time for polycystic kidney disease: does one shot of roscovitine bring the cure?
Kuehn EW; Walz G
Nephrol Dial Transplant; 2007 Aug; 22(8):2133-5. PubMed ID: 17412700
[No Abstract] [Full Text] [Related]
17. Structural basis for the potent and selective inhibition of casein kinase 1 epsilon.
Long AM; Zhao H; Huang X
J Med Chem; 2012 Nov; 55(22):10307-11. PubMed ID: 23106386
[TBL] [Abstract][Full Text] [Related]
18. Transgenic overexpression of prothymosin alpha induces development of polycystic kidney disease.
Li KJ; Shiau AL; Chiou YY; Yo YT; Wu CL
Kidney Int; 2005 May; 67(5):1710-22. PubMed ID: 15840017
[TBL] [Abstract][Full Text] [Related]
19. Discoidin Domain Receptor 1 (DDR1) tyrosine kinase is upregulated in PKD kidneys but does not play a role in the pathogenesis of polycystic kidney disease.
Soomro I; Hong A; Li Z; Duncan JS; Skolnik EY
PLoS One; 2019; 14(7):e0211670. PubMed ID: 31260458
[TBL] [Abstract][Full Text] [Related]
20. Calotropin: a cardenolide from calotropis gigantea that inhibits Wnt signaling by increasing casein kinase 1α in colon cancer cells.
Park HY; Toume K; Arai MA; Sadhu SK; Ahmed F; Ishibashi M
Chembiochem; 2014 Apr; 15(6):872-8. PubMed ID: 24644251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
